3 transcripts
STVN
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
of 2 different production sites into a single location so that the Danish team can focus on the advancement of our assembly and packaging technologies
STVN
Earnings call transcript
NYSE
2024 Q1
9 May 24
due to lower sales from pharmaceutical visual inspection and assembly and packaging lines. As previously discussed, our main priority in 2024
STVN
Earnings call transcript
NYSE
2023 Q4
7 Mar 24
the possible impact with our new secondary packaging, innovative and secondary packaging that is possible applicable also to the syringe market. So
- Prev
- 1
- Next